Elevated levels of ICAM-1 are associated with various inflammatory and autoimmune diseases, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It is also implicated in cardiovascular diseases, where its expression on endothelial cells contributes to the adhesion of monocytes and the formation of atherosclerotic plaques.
